UNIVERSITY OF EDINBURGH

The DUAL-ACS trial found that 3 months of dual antiplatelet therapy (DAPT) showed signals for improved survival and lower bleeding risk compared to the standard 12-month duration in real-world heart attack patients.

A new non-hormonal male contraceptive implant called Adam has demonstrated effectiveness for at least two years in initial clinical trials, with no sperm detected in participants reaching the 24-month mark.

New research from Denmark shows antidepressant use is associated with an increased risk of sudden cardiac death, with risk rising based on duration of exposure.

AI technology developed at Washington University can analyze sequential mammograms to identify subtle tissue changes, predicting breast cancer risk 2.3 times more accurately than standard methods.

Scottish researchers discover that combining cladribine with lenvatinib nearly eradicates hepatocellular carcinoma tumors in groundbreaking preclinical study led by Professor Tom Bird.

A randomized clinical trial involving 224 patients revealed that early aortic valve intervention did not significantly reduce the composite outcome of all-cause death or unplanned aortic stenosis-related hospitalization.

The EVOLVED study found that early aortic valve replacement (AVR) in asymptomatic patients with myocardial fibrosis did not reduce all-cause mortality or unplanned aortic stenosis-related hospitalizations.

A new study suggests that Sodium-glucose cotransporter-2 (SGLT-2) inhibitors, used for treating type 2 diabetes, are associated with a lower risk of developing dementia.